Long-term Safety and Clinical Benefit of Mepolizumab in Patients With the Most Severe Eosinophilic Asthma: The COSMEX Study
Sandhya Khurana
(1)
,
Guy Brusselle
(2)
,
Elisabeth Bel
(3)
,
J. Mark Fitzgerald
(4)
,
Matthew Masoli
(5)
,
Stephanie Korn
(6)
,
Motokazu Kato
(7)
,
Frank Albers
(8)
,
Eric Bradford
(8)
,
Martyn Gilson
(9)
,
Robert Price
(10, 11)
,
Marc Humbert
(12, 13, 14, 15)
1
University of Rochester [USA]
2 Ghent University Hospital
3 Amsterdam UMC - Amsterdam University Medical Center
4 UBC and VGH Divisions of Respiratory Medicine [Vancouver, BC, Canada]
5 University of Exeter
6 UKB - Universitätsklinikum Bonn
7 KCH - Kishiwada City Hospital [Osaka, Japan]
8 GSK - GlaxoSmithKline [Research Triangle Park]
9 GSK, Uxbridge, Middlesex, UK.
10 OCDE - Organisation de Coopération et de Développement Economiques = Organisation for Economic Co-operation and Development
11 GSK - GlaxoSmithKline [Stevenage, UK]
12 HPPIT - Hypertension arterielle pulmonaire physiopathologie et innovation thérapeutique
13 UP11 UFR Médecine - Université Paris-Sud - Paris 11 - Faculté de médecine
14 Université Paris-Saclay
15 Service de pneumologie [CHU Bicêtre]
2 Ghent University Hospital
3 Amsterdam UMC - Amsterdam University Medical Center
4 UBC and VGH Divisions of Respiratory Medicine [Vancouver, BC, Canada]
5 University of Exeter
6 UKB - Universitätsklinikum Bonn
7 KCH - Kishiwada City Hospital [Osaka, Japan]
8 GSK - GlaxoSmithKline [Research Triangle Park]
9 GSK, Uxbridge, Middlesex, UK.
10 OCDE - Organisation de Coopération et de Développement Economiques = Organisation for Economic Co-operation and Development
11 GSK - GlaxoSmithKline [Stevenage, UK]
12 HPPIT - Hypertension arterielle pulmonaire physiopathologie et innovation thérapeutique
13 UP11 UFR Médecine - Université Paris-Sud - Paris 11 - Faculté de médecine
14 Université Paris-Saclay
15 Service de pneumologie [CHU Bicêtre]